Endonovo acquires Rio Grande Neurosciences for M

Endonovo Therapeutics (OTCQB:ENDV -7%) acquires privately held Santa Fe, NM-based Rio Grande Neurosciences for $30M in cash, stock and assumption of debt. Rio Grande develops non-invasive brain stimulation technologies called Electroceuticals. Endonovo’s two technology platforms are Immunotronics, a non-invasive, non-implantable bioelectric device for treating/preventing organ failure through the reduction of inflammation and necrosis, and Cytotronics, a method for expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields for tissue engineering and cell therapies.


Link to Full Article: Endonovo acquires Rio Grande Neurosciences for M